What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Virus
Joaquim Gascon focuses on Chagas disease, Immunology, Epidemiology, Trypanosoma cruzi and Trypanosomiasis.
He interconnects Benznidazole, Environmental health, Intensive care medicine, Transmission and Disease in the investigation of issues within Chagas disease.
His Benznidazole research incorporates elements of Nifurtimox and Internal medicine, Adverse effect.
His Immunology research focuses on subjects like Pharmacotherapy, which are linked to Standard treatment.
His Epidemiology research is multidisciplinary, relying on both Etiology, Tropical medicine, Obstructive sleep apnea, Severity of illness and Pediatrics.
His Trypanosoma cruzi research includes themes of Parasitemia and Virology.
His most cited work include:
- Chagas disease in Spain, the United States and other non-endemic countries. (417 citations)
- Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples (243 citations)
- Neurological complications of dengue virus infection. (221 citations)
What are the main themes of his work throughout his whole career to date?
Chagas disease, Immunology, Virology, Epidemiology and Internal medicine are his primary areas of study.
Joaquim Gascon has included themes like Benznidazole, Trypanosoma cruzi, Transmission, Disease and Serology in his Chagas disease study.
Joaquim Gascon has researched Immunology in several fields, including Pharmacotherapy and Intensive care medicine.
His work is dedicated to discovering how Virology, Microbiology are connected with Escherichia coli, Traveler's diarrhea and Shigella sonnei and other disciplines.
His Epidemiology research is multidisciplinary, incorporating elements of Incidence, Environmental health, Tropical medicine, Public health and Pediatrics.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Cardiology.
He most often published in these fields:
- Chagas disease (28.47%)
- Immunology (23.96%)
- Virology (18.40%)
What were the highlights of his more recent work (between 2017-2021)?
- Chagas disease (28.47%)
- Trypanosoma cruzi (14.24%)
- Internal medicine (15.97%)
In recent papers he was focusing on the following fields of study:
His main research concerns Chagas disease, Trypanosoma cruzi, Internal medicine, Benznidazole and Immunology.
His Chagas disease study incorporates themes from Infectious disease, Epidemiology, Chronic Chagas' disease, Public health and Serology.
His Trypanosoma cruzi research integrates issues from IC50, Healthcare system, Disease and Virology.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Quinine and Artesunate.
His work carried out in the field of Benznidazole brings together such families of science as Adverse effect, Placebo, Clinical trial and Nifurtimox.
His work on Plasma derived as part of general Immunology research is frequently linked to Extracellular vesicles, bridging the gap between disciplines.
Between 2017 and 2021, his most popular works were:
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. (117 citations)
- Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. (89 citations)
- Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Virus
His primary areas of investigation include Chagas disease, Trypanosoma cruzi, Internal medicine, Benznidazole and Clinical trial.
His study in Chagas disease is interdisciplinary in nature, drawing from both Gastroenterology, Chronic Chagas' disease, Public health, Serology and Dilated cardiomyopathy.
His work in Trypanosoma cruzi addresses issues such as Intensive care medicine, which are connected to fields such as Stroke, Sudden death and Heart failure.
Joaquim Gascon combines subjects such as Transmission, Staphylococcal Skin Infections and Travel medicine with his study of Internal medicine.
His research in Benznidazole intersects with topics in Placebo, Nifurtimox, Disease and Immunology.
Joaquim Gascon performs multidisciplinary study on Immunology and Posaconazole in his works.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
